Impact of estradiol, ER subtype specific agonists and genistein on energy homeostasis in a rat model of nutrition induced obesity

Molecular and Cellular Endocrinology

Volumn 351, Issue 2, 2012, Pages 227-238

  Weigt, Carmen ^a   Hertrampf, Torsten ^a,c   Zoth, Nora ^a   Fritzemeier, Karl Heinrich ^b   Diel, Patrick ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^b BAYER PHARMA AG   (Germany)

^c GRÜNENTHAL GMBH   (Germany)

Author keywords

ER subtype selective agonists; Estrogen receptor beta; Genistein; Lipid metabolism; Obesity; Skeletal muscle

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; LEPTIN; LIPID; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CELL SIZE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENERGY BALANCE; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE LOCATION; HORMONE ACTION; IGF1 GENE; INTRAABDOMINAL FAT; LIPID BLOOD LEVEL; LIPID DIET; LIPID METABOLISM; MUSCLE CELL; MUSCLE MASS; NONHUMAN; OBESITY; OVARIECTOMY; PAX7 GENE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SOLEUS MUSCLE;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; DIET, HIGH-FAT; ENERGY METABOLISM; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENISTEIN; HOMEOSTASIS; INSULIN-LIKE GROWTH FACTOR I; INTRA-ABDOMINAL FAT; LEPTIN; LIPIDS; MUSCLE, SKELETAL; OBESITY; PAIRED BOX TRANSCRIPTION FACTORS; RATS; RATS, WISTAR;

EID: 84857141470     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.12.013     Document Type: Article

References (90)

1. Baker J.S., McCormick M.C., Robergs R.A. Interaction among skeletal muscle metabolic energy systems during intense exercise. J. Nutr. Metab. 2010, 905612.
2. Barsh G.S., Schwartz M.W. Genetic approaches to studying energy balance. perception and integration. Nat. Rev. Genet. 2002, 3:589-600.
3. Barton-Davis E.R., Shoturma D.I., Musaro A., Rosenthal N., Sweeney H.L. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc. Natl. Acad. Sci. USA 1998, 95:15603-15607.
4. Barton-Davis E.R., Shoturma D.I., Sweeney H.L. Contribution of satellite cells to IGF-I induced hypertrophy of skeletal muscle. Acta Physiol. Scand. 1999, 167:301-305.
5. Baxter J.D., Young W.F., Webb P. Cardiovascular endocrinology: introduction. Endocr. Rev. 2003, 24:253-260.
6. Bierman E.L. George Lyman Duff Memorial Lecture. Atherogenesis in diabetes, Arterioscler Thromb. 1992, 12:647-656.
7. Bonen A., Tan M.H. Differences in insulin binding capacity in metabolically distinct skeletal muscle. Horm. Metab. Res. 1981, 13:362.
8. Caballero B. The global epidemic of obesity: an overview. Epidemiol. Rev. 2007, 29:1-5.
9. Chan R.S., Woo J. Prevention of overweight and obesity: how effective is the current public health approach. Int. J. Environ. Res. Public Health. 2010, 7:765-783.
10. Charge S.B., Rudnicki M.A. Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 2004, 84:209-238.
11. Chen J.C., Goldhamer D.J. Skeletal muscle stem cells. Reprod. Biol. Endocrinol. 2003, 1:101.
12. Comuzzie A.G., Williams J.T., Martin L.J., Blangero J. Searching for genes underlying normal variation in human adiposity. J. Mol. Med. 2001, 79:57-70.
13. Cooke P.S., Naaz A. Role of estrogens in adipocyte development and function. Exp. Biol Med. (Maywood) 2004, 229:1127-1135.
14. D'Eon T.M., Souza S.C., Aronovitz M., Obin M.S., Fried S.K., Greenberg A.S. Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J. Biol. Chem. 2005, 280:35983-35991.
15. Delp M.D., Duan C. Composition and size of type I, IIA, IID/X, and IIB fibers and citrate synthase activity of rat muscle. J. Appl. Physiol. 1996, 80:261-270.
16. Diel P. Tissue-specific estrogenic response and molecular mechanisms. Toxicol. Lett. 2002, 127:217-224.
17. Diel P., Geis R.B., Caldarelli A., Schmidt S., Leschowsky U.L., Voss A., Vollmer G. The differential ability of the phytoestrogen genistein and of estradiol to induce uterine weight and proliferation in the rat is associated with a substance specific modulation of uterine gene expression. Mol. Cell Endocrinol. 2004, 221:21-32.
18. Dubey R.K., Imthurn B., Barton M., Jackson E.K. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Cardiovasc. Res. 2005, 66:295-306.
19. Enns D.L., Tiidus P.M. Estrogen influences satellite cell activation and proliferation following downhill running in rats. J. Appl. Physiol. 2008, 104:347-353.
20. Foryst-Ludwig A., Clemenz M., Hohmann S., Hartge M., Sprang C., Frost N., Krikov M., Bhanot S., Barros R., Morani A., Gustafsson J.A., Unger T., Kintscher U. Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma. PLoS Genet. 2008, 4:e1000108.
21. Friedman, J.M., 2002. The function of leptin in nutrition, weight, and physiology, Nutr Rev. 60, S1-14; discussion S68-84, 85-7.
22. Furuhata Y., Kagaya R., Hirabayashi K., Ikeda A., Chang K.T., Nishihara M., Takahashi M. Development of obesity in transgenic rats with low circulating growth hormone levels: involvement of leptin resistance. Eur. J. Endocrinol. 2000, 143:535-541.
23. Goulart A.C., Zee R.Y., Rexrode K.M. Estrogen receptor 1 gene polymorphisms and decreased risk of obesity in women. Metabolism 2009, 58:759-764.
24. Hawke T.J., Garry D.J. Myogenic satellite cells: physiology to molecular biology. J. Appl. Physiol. 2001, 91:534-551.
25. Hegele-Hartung C., Siebel P., Peters O., Kosemund D., Muller G., Hillisch A., Walter A., Kraetzschmar J., Fritzemeier K.H. Impact of isotype-selective estrogen receptor agonists on ovarian function. Proc. Natl. Acad. Sci. USA 2004, 101:5129-5134.
26. Heine P.A., Taylor J.A., Iwamoto G.A., Lubahn D.B., Cooke P.S. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc. Natl. Acad. Sci. USA 2000, 97:12729-12734.
27. Heldring N., Pike A., Andersson S., Matthews J., Cheng G., Hartman J., Tujague M., Strom A., Treuter E., Warner M., Gustafsson J.A. Estrogen receptors: how do they signal and what are their targets. Physiol. Rev. 2007, 87:905-931.
28. Hertrampf T., Degen G.H., Kaid A.A., Laudenbach-Leschowsky U., Seibel J., Di Virgilio A.L., Diel P. Combined effects of physical activity, dietary isoflavones and 17beta-estradiol on movement drive, body weight and bone mineral density in ovariectomized female rats. Planta Med. 2006, 72:484-487.
29. Hertrampf T., Gruca M.J., Seibel J., Laudenbach U., Fritzemeier K.H., Diel P. The bone-protective effect of the phytoestrogen genistein is mediated via ER alpha-dependent mechanisms and strongly enhanced by physical activity. Bone 2007, 40:1529-1535.
30. Hertrampf T., Schleipen B., Velders M., Laudenbach U., Fritzemeier K.H., Diel P. Estrogen receptor subtype-specific effects on markers of bone homeostasis. Mol. Cell. Endocrinol. 2008, 291:104-108.
31. Hertrampf T., Schmidt S., Laudenbach-Leschowsky U., Seibel J., Diel P. Tissue-specific modulation of cyclooxygenase-2 (Cox-2) expression in the uterus and the v. Cava by estrogens and phytoestrogens. Mol. Cell Endocrinol. 2005, 243:51-57.
32. Hertrampf T., Seibel J., Laudenbach U., Fritzemeier K.H., Diel P. Analysis of the effects of oestrogen receptor alpha (ERalpha)- and ERbeta-selective ligands given in combination to ovariectomized rats. Br. J. Pharmacol. 2008, 153:1432-1437.
33. Hillisch A., Peters O., Kosemund D., Muller G., Walter A., Schneider B., Reddersen G., Elger W., Fritzemeier K.H. Dissecting physiological roles of estrogen receptor alpha and beta with potent selective ligands from structure-based design. Mol. Endocrinol. 2004, 18:1599-1609.
34. Homma H., Kurachi H., Nishio Y., Takeda T., Yamamoto T., Adachi K., Morishige K., Ohmichi M., Matsuzawa Y., Murata Y. Estrogen suppresses transcription of lipoprotein lipase gene. Existence of a unique estrogen response element on the lipoprotein lipase promoter. J. Biol. Chem. 2000, 275:11404-11411.
35. James D.E., Zorzano A., Boni-Schnetzler M., Nemenoff R.A., Powers A., Pilch P.F., Ruderman N.B. Intrinsic differences of insulin receptor kinase activity in red and white muscle. J. Biol. Chem. 1986, 261:14939-14944.
36. Janovska A., Hatzinikolas G., Mano M., Wittert G.A. The effect of dietary fat content on phospholipid fatty acid profile is muscle fiber type dependent. Am. J. Physiol. Endocrinol. Metab. 2010, 298:E779-E786.
37. Kamohara S., Burcelin R., Halaas J.L., Friedman J.M., Charron M.J. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 1997, 389:374-377.
38. Kern M., Wells J.A., Stephens J.M., Elton C.W., Friedman J.E., Tapscott E.B., Pekala P.H., Dohm G.L. Insulin responsiveness in skeletal muscle is determined by glucose transporter (Glut4) protein level. Biochem. J. 1990, 270:397-400.
39. Kim H.K., Nelson-Dooley C., Della-Fera M.A., Yang J.Y., Zhang W., Duan J., Hartzell D.L., Hamrick M.W., Baile C.A. Genistein decreases food intake, body weight, and fat pad weight and causes adipose tissue apoptosis in ovariectomized female mice. J. Nutr. 2006, 136:409-414.
40. Kirk E.A., Sutherland P., Wang S.A., Chait A., LeBoeuf R.C. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. J. Nutr. 1998, 128:954-959.
41. Kristensen K., Pedersen S.B., Vestergaard P., Mosekilde L., Richelsen B. Hormone replacement therapy affects body composition and leptin differently in obese and non-obese postmenopausal women. J. Endocrinol. 1999, 163:55-62.
42. Kuang S., Charge S.B., Seale P., Huh M., Rudnicki M.A. Distinct roles for Pax7 and Pax3 in adult regenerative myogenesis. J. Cell. Biol. 2006, 172:103-113.
43. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., Gustafsson J.A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997, 138:863-870.
44. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139:4252-4263.
45. Kushwaha R.S., Foster D.M., Barrett P.H., Carey K.D. Effect of estrogen and progesterone on metabolism of apoprotein B in baboons. Am. J. Physiol. 1990, 258:E172-E183.
46. Lee Y.M., Choi J.S., Kim M.H., Jung M.H., Lee Y.S., Song J. Effects of dietary genistein on hepatic lipid metabolism and mitochondrial function in mice fed high-fat diets. Nutrition 2006, 22:956-964.
47. Ley C.J., Lees B., Stevenson J.C. Sex- and menopause-associated changes in body-fat distribution. Am. J. Clin. Nutr. 1992, 55:950-954.
48. Liang Y.Q., Akishita M., Kim S., Ako J., Hashimoto M., Iijima K., Ohike Y., Watanabe T., Sudoh N., Toba K., Yoshizumi M., Ouchi Y. Estrogen receptor beta is involved in the anorectic action of estrogen. Int. J. Obes. Relat. Metab. Disord. 2002, 26:1103-1109.
49. Ling S., Komesaroff P., Sudhir K. Cellular mechanisms underlying the cardiovascular actions of oestrogens. Clin. Sci. (Lond) 2006, 111:107-118.
50. Low S., Chin M.C., Deurenberg-Yap M. Review on epidemic of obesity. Ann. Acad. Med. Singapore 2009, 38:57-59.
51. Maffei M., Halaas J., Ravussin E., Pratley R.E., Lee G.H., Zhang Y., Fei H., Kim S., Lallone R., Ranganathan S., et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1995, 1:1155-1161.
52. Matthews J., Gustafsson J.A. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol. Interv. 2003, 3:281-292.
53. Mavalli M.D., DiGirolamo D.J., Fan Y., Riddle R.C., Campbell K.S., van Groen T., Frank S.J., Sperling M.A., Esser K.A., Bamman M.M., Clemens T.L. Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice. J. Clin. Invest. 2010, 120:4007-4020.
54. Meli R., Pacilio M., Raso G.M., Esposito E., Coppola A., Nasti A., Di Carlo C., Nappi C., Di Carlo R. Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats. Endocrinology 2004, 145:3115-3121.
55. Michael McClain R., Wolz E., Davidovich A., Pfannkuch F., Edwards J.A., Bausch J. Acute, subchronic and chronic safety studies with genistein in rats. Food Chem. Toxicol. 2006, 44:56-80.
56. Minokoshi Y., Kim Y.B., Peroni O.D., Fryer L.G., Muller C., Carling D., Kahn B.B. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 2002, 415:339-343.
57. Mokdad A.H., Ford E.S., Bowman B.A., Dietz W.H., Vinicor F., Bales V.S., Marks J.S. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. Jama 2003, 289:76-79.
58. Morrison C.D. Leptin resistance and the response to positive energy balance. Physiol. Behav. 2008, 94:660-663.
59. Morton G.J., Cummings D.E., Baskin D.G., Barsh G.S., Schwartz M.W. Central nervous system control of food intake and body weight. Nature 2006, 443:289-295.
60. Naaz A., Yellayi S., Zakroczymski M.A., Bunick D., Doerge D.R., Lubahn D.B., Helferich W.G., Cooke P.S. The soy isoflavone genistein decreases adipose deposition in mice. Endocrinology 2003, 144:3315-3320.
61. Naaz A., Zakroczymski M., Heine P., Taylor J., Saunders P., Lubahn D., Cooke P.S. Effect of ovariectomy on adipose tissue of mice in the absence of estrogen receptor alpha (ERalpha): a potential role for estrogen receptor beta (ERbeta). Horm. Metab. Res. 2002, 34:758-763.
62. Newbold R.R., Padilla-Banks E., Jefferson W.N. Environmental estrogens and obesity. Mol. Cell. Endocrinol. 2009, 304:84-89.
63. Ohmichi M., Tasaka K., Kurachi H., Murata Y. Molecular mechanism of action of selective estrogen receptor modulator in target tissues. Endocr. J. 2005, 52:161-167.
64. Owens J.W., Ashby J. Critical review and evaluation of the uterotrophic bioassay for the identification of possible estrogen agonists and antagonists: in support of the validation of the OECD uterotrophic protocols for the laboratory rodent. Organisation for economic co-operation and development. Crit. Rev. Toxicol. 2002, 32:445-520.
65. Pelzer T., Jazbutyte V., Hu K., Segerer S., Nahrendorf M., Nordbeck P., Bonz A.W., Muck J., Fritzemeier K.H., Hegele-Hartung C., Ertl G., Neyses L. The estrogen receptor-alpha agonist 16alpha-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats. Cardiovasc. Res. 2005, 67:604-612.
66. Penza M., Montani C., Romani A., Vignolini P., Pampaloni B., Tanini A., Brandi M.L., Alonso-Magdalena P., Nadal A., Ottobrini L., Parolini O., Bignotti E., Calza S., Maggi A., Grigolato P.G., Di Lorenzo D. Genistein affects adipose tissue deposition in a dose-dependent and gender-specific manner. Endocrinology 2006, 147:5740-5751.
67. Philippou A., Maridaki M., Halapas A., Koutsilieris M. The role of the insulin-like growth factor 1 (IGF-1) in skeletal muscle physiology. In Vivo 2007, 21:45-54.
68. Reagan-Shaw S., Nihal M., Ahmad N. Dose translation from animal to human studies revisited. Faseb. J. 2008, 22:659-661.
69. Rogers N.H., Perfield J.W., Strissel K.J., Obin M.S., Greenberg A.S. Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity. Endocrinology 2009, 150:2161-2168.
70. Ropero A.B., Alonso-Magdalena P., Quesada I., Nadal A. The role of estrogen receptors in the control of energy and glucose homeostasis. Steroids 2008, 73:874-879.
71. Rosen E.D., Spiegelman B.M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006, 444:847-853.
72. Sbarouni E., Kyriakides Z.S., Kremastinos D. The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease. J. Am. Coll. Cardiol. 1998, 32:1244-1250.
73. Schaefer E.J. Lipoproteins, nutrition, and heart disease. Am. J. Clin. Nutr. 2002, 75:191-212.
74. Schwartz M.W. Brain pathways controlling food intake and body weight. Exp. Biol. Med. (Maywood) 2001, 226:978-981.
75. Schwartz M.W. Central nervous system regulation of food intake. Obesity (Silver Spring) 2006, 14(Suppl 1):1S-8S.
76. Schwartz M.W., Seeley R.J., Campfield L.A., Burn P., Baskin D.G. Identification of targets of leptin action in rat hypothalamus. J. Clin. Invest. 1996, 98:1101-1106.
77. Scott W., Stevens J., Binder-Macleod S.A. Human skeletal muscle fiber type classifications. Phys. Ther. 2001, 81:1810-1816.
78. Svensson J., Moverare-Skrtic S., Windahl S., Swanson C., Sjogren K. Stimulation of both estrogen and androgen receptors maintains skeletal muscle mass in gonadectomized male mice but mainly via different pathways. J. Mol. Endocrinol. 2010, 45:45-57.
79. Swinburn B.A., Caterson I., Seidell J.C., James W.P. Diet, nutrition and the prevention of excess weight gain and obesity. Public Health Nutr. 2004, 7:123-146.
80. Taylor A.H., Al-Azzawi F. Immunolocalisation of oestrogen receptor beta in human tissues. J. Mol. Endocrinol. 2000, 24:145-155.
81. Tiidus P.M., Deller M., Liu X.L. Oestrogen influence on myogenic satellite cells following downhill running in male rats: a preliminary study. Acta Physiol. Scand 2005, 184:67-72.
82. Toth M.J., Tchernof A., Sites C.K., Poehlman E.T. Effect of menopausal status on body composition and abdominal fat distribution. Int. J. Obes. Relat. Metab. Disord. 2000, 24:226-231.
83. Toth M.J., Tchernof A., Sites C.K., Poehlman E.T. Menopause-related changes in body fat distribution. Ann. N Y Acad. Sci. 2000, 904:502-506.
84. van Beek A.P., de Ruijter-Heijstek F.C., Erkelens D.W., de Bruin T.W. Menopause is associated with reduced protection from postprandial lipemia. Arterioscler. Thromb. Vasc. Biol. 1999, 19:2737-2741.
85. Velders, M., 2011. Gender-specific Mechanisms of Skeletal Muscle Regeneration & Adaptation, Dissertation. German Sports University, Cologne.
86. Wade G.N., Powers J.B. Tamoxifen antagonizes the effects of estradiol on energy balance and estrous behavior in Syrian hamsters. Am. J. Physiol. 1993, 265:R559-R562.
87. Wasan K.M., Looije N.A. Emerging pharmacological approaches to the treatment of obesity. J. Pharm. Pharm. Sci. 2005, 8:259-271.
88. Weber M.M. Effects of growth hormone on skeletal muscle. Horm Res. 2002, 58(Suppl 3):43-48.
89. Yang J.Y., Lee S.J., Park H.W., Cha Y.S. Effect of genistein with carnitine administration on lipid parameters and obesity in C57Bl/6J mice fed a high-fat diet. J. Med. Food 2006, 9:459-467.
90. Zoth N., Weigt C., Laudenbach-Leschowski U., Diel P. Physical activity and estrogen treatment reduce visceral body fat and serum levels of leptin in an additive manner in a diet induced animal model of obesity. J. Steroid. Biochem. Mol. Biol. 2010, 122:100-105.